. 2018 Mar 27;20(3):253–259. doi: 10.4103/aja.aja_9_18
Copyright: © The Author(s)(2018)
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Table 1.
Select clinical trials evaluating immunotherapy in prostate cancer
